Table 3.
SDNN, ms | SDNNindex, ms | SDANN, ms | |
---|---|---|---|
Continuous variables | |||
logCRP | r =–0.28‡ | r =–0.24‡ | r =–0.24‡ |
Age, years | r =–0.04 | r =–0.02 | r =–0.07 |
Body‐mass index, kg/m2 | r =–0.07 | r =–0.05 | r =–0.05 |
Total cholesterol, mmol/L | r =–0.05 | r =–0.06 | r =–0.04 |
LDL cholesterol, mmol/L | r =–0.05 | r =–0.01 | r =–0.05 |
HDL cholesterol, mmol/L | r = 0.11 | r = 0.07 | r = 0.10 |
Triglycerides, mmol/L | r =–0.11 | r =–0.14* | r =–0.09 |
Blood glucose, mmol/L | r =–0.02 | r = 0.03 | r =–0.03 |
LVEF, % | r = 0.09 | r = 0.13* | r = 0.07 |
Categorical variables | |||
± coronary artery stenosis | 122 ± 32 vs 129 ± 35 | 48 ± 14 vs 51 ± 15 | 111 ± 33 vs 116 ± 35 |
± previous MI | 120 ± 31 vs 126 ± 34 | 47 ± 13 vs 50 ± 14 | 109 ± 31 vs 113 ± 34 |
± smoking | 113 ± 30 vs 131 ± 33‡ | 44 ± 12 vs 52 ± 14‡ | 102 ± 31 vs 118 ± 33‡ |
Male vs female | 128 ± 34 vs 119 ± 31 | 50 ± 14 vs 47 ± 13 | 115 ± 34 vs 108 ± 31 |
± beta‐blocker | 121 ± 33 vs 129 ± 34 | 50 ± 14 vs 47 ± 13 | 107 ± 33 vs 118 ± 33† |
± ACE inhibitor | 124 ± 36 vs 125 ± 33 | 48 ± 13 vs 49 ± 14 | 112 ± 36 vs 112 ± 33 |
± hypertension | 121 ± 34 vs 127 ± 33 | 47 ± 11 vs 52 ± 15 | 109 ± 36 vs 115 ± 33 |
± diabetes | 124 ± 37 vs 125 ± 33 | 50 ± 18 vs 49 ± 14 | 111 ± 36 vs 113 ± 33 |
*P < 0.05; †P < 0.01; ‡P < 0.001 (Spearman's rank correlation for continuous variables, Mann–Whitney test for discontinuous variables).
MI = myocardial infarction; LVEF = left ventricular ejection fraction.